Siemens says the FDA approved a 3D tomosynthesis option for its Mammomat Inspiration digital mammography device.
Siemens Healthcare (NYSE:SI) today said the FDA approved a new breast tomosynthesis option for its Mammomat Inspiration digital mammography device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DmIVBr
Cap comentari:
Publica un comentari a l'entrada